coagulation factor VII
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The F7 gene provides instructions for making a protein called coagulation factor VII. Coagulation factors are a group of related proteins that are involved in the coagulation system, which is a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.
Video picks for GenesVideo library
Normal function
The F7 gene provides instructions for making a protein called coagulation factor VII. Coagulation factors are a group of related proteins that are involved in the coagulation system, which is a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.
Coagulation factor VII is made primarily by cells in the liver. The protein circulates in the bloodstream in an inactive form until the coagulation system is turned on (activated) by an injury that damages blood vessels. Activated coagulation factor VII helps turn on other coagulation factors in turn. This step-wise process ultimately promotes the conversion of an important coagulation protein called fibrinogen into fibrin, which is the material that forms blood clots.
Conditions referring to this gene or chromosome
Other names
FVII coagulation protein
proconvertin
serum prothrombin conversion accelerator
SPCA
Patient picks for Genes

Cancer
Breast cancer facts and risk factors
Most cases of breast cancer occur by chance. However, breast cancer does occur more often than usual in some families because of their genetic makeup.
by Dr Colin Tidy, MRCGP

Heart health and blood vessels
Dilated cardiomyopathy causes: what are the risk factors?
Having dilated cardiomyopathy means that your heart muscle is weakened, which affects how your heart pumps blood around your body. There are a wide range of dilated cardiomyopathy causes, including genetics, other health conditions, alcohol consumption and a poor diet. While we can't control some of these risk factors, we can make positive lifestyle changes to reduce our risk of developing dilated cardiomyopathy.
by Amberley Davis

Treatment and medication
What factors are causing antimicrobial resistance?
Following a recent study by health economists at the University of Manchester and the University of Southern Denmark, the tremendous pressure GPs are currently working under has been linked to increasing broad-spectrum antibiotic prescribing in England. Because excess antibiotic prescribing has been closely linked to antibiotic resistance, there are concerns that these higher prescribing levels may be contributing to antimicrobial resistance.
by Emily Jane Bashforth

Breast cancer types, detection and risks
What are the risk factors for breast cancer?
Dr Sarah Jarvis MBE Although breast cancer can develop for no apparent reason, there are certain risk factors which increase the chance that breast cancer will develop. [https://patient.info/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet)
by Dr Sarah Jarvis

High blood pressure
What is high blood pressure?
Dr Yassir Javaid High blood pressure happens when the force on the walls of blood vessels (caused by the blood within them) is more than normal. This means the heart has to work harder and the blood vessels are under more strain, making it a major risk factor for heart disease, stroke and other serious conditions. Healthcare professionals sometimes call high blood pressure 'hypertension'. [https://patient.info/health/high-blood-pressure-hypertension](https://patient.info/health/high-blood-pressure-hypertension)
by Dr Yassir Javaid, MRCGP

Type 1 diabetes
Is type 1 diabetes hereditary?
Dr Partha Kar Although type 1 diabetes is not an inherited disease, there is some genetic factor. A first-degree relative (sister, brother, son, daughter) of someone with type 1 diabetes has about a 1 in 16 chance of developing type 1 diabetes. For more information on type 1 diabetes, go to [https://patient.info/health/type-1-diabetes](https://patient.info/health/type-1-diabetes)
by Dr Partha Kar, FRCP
Related patient information and medicines

Patient information leaflet
Thrombophilia
It can lead to venous blood clots, often in unusual sites such as the veins of the gut, liver or... Anticoagulation may be needed and there are other treatments too for this condition. Elevated factor VIII This is pronounced 'factor 8'. It is due to abnormally high levels of factor VIII, which is one of the blood chemicals that promotes clotting..

Patient information leaflet
Blood clotting tests
Blood clotting tests are used to diagnose and assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. One or more of these tests may be done if a gene... For example, the amount of factor VIII can be measured in a blood sample. (The level is very low or absent in people with haemophilia A.) Platelet.

Patient information leaflet
Haemophilia
Haemophilia is a rare bleeding disorder that affects your ability to make a clot. The blood contains substances called clotting factors that work with platelets to form a clot. When you injure yourself the clot stops you bleeding... A newer treatment has been developed that does not directly replace the clotting factor. It is a monoclonal antibody.

Patient information leaflet
Barrett's oesophagus
Barrett'. It typically affects people between the ages of 50 and 70 years. The coil then emits heat ene... Nearby normal cells then multiply and replace the destroyed abnormal cells. Argon plasma coagulation This treatment uses a jet of argon gas, together with an electric current, to burn away dysplastic cells. Endoscopic mucosal resection (EMR).

Patient information leaflet
Pre-eclampsia
Complications Most women with pre-eclampsia or HE... The risk of complications increases the more severe the pre-eclampsia becomes. The risk of complications is reduced if pre-eclampsia is diagnosed early and treated. A rare but serious complication is disseminated intravascular coagulation, which can occur if a woman has had to have many blood.

Patient information leaflet
Piles
The piles then die and drop off, similar to after banding. Infrared coagulation/photocoagulation This method of piles treatment uses infrared light to burn and cut off the circulation to the haemorrhoid, which causes it to shrink in size. It may be as effective as banding treatment and injection sclerotherapy for first- and second-degree piles..
Further reading and references
- coagulation factor VII; MedlinePlus, National Library of Medicine.
- Girolami A, Cosi E, Santarossa C, Ferrari S, Luigia Randi M. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII. Semin Thromb Hemost. 2015 Jun;41(4):366-73. doi: 10.1055/s-0035-1549851. Epub 2015 May 14.
- Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, De Bosch N, Salazar-Sanchez L; Greifswald Factor FVII Deficiency Study Group. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia. 2009 Jan;15(1):267-80. doi: 10.1111/j.1365-2516.2008.01910.x. Epub 2008 Oct 30.
- Mariani G, Bernardi F. Factor VII Deficiency. Semin Thromb Hemost. 2009 Jun;35(4):400-6. doi: 10.1055/s-0029-1225762. Epub 2009 Jul 13.
- Mariani G, Herrmann FH, Bernardi F, Schved JF, Auerswald G, Ingerslev J. Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7). Blood. 2000 Jul 1;96(1):374. No abstract available.
- Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, Wulff K, Schved JF, Auerswald G, Ingerslev J, Bernardi F; International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005 Mar;93(3):481-7. doi: 10.1160/TH04-10-0650.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

